MSN: Gossamer Bio plans FDA talks after narrow miss in key pivotal study, stock sinks
Gossamer Bio Inc. GOSS dropped during early trading on Monday after the company shared topline results from the Phase 3 PROSERA study evaluating seralutinib in pulmonary arterial hypertension. PAH is ...
Gossamer Bio plans FDA talks after narrow miss in key pivotal study, stock sinks
Seeking Alpha: Gossamer Bio Announces Completion of Enrollment in Registrational Phase 3 PROSERA Study for the Treatment of PAH
Gossamer Bio Announces Completion of Enrollment in Registrational Phase 3 PROSERA Study for the Treatment of PAH
TweakTown: 'Radeon Monster Profile' tool for RDNA 2: RX 6800 XT beats RTX 3090 Ti
We are only weeks away from AMD's big next-gen Radeon RX 7000 series "RDNA 3" graphics cards reveal on November 3, but ahead of that there's Radeon Monster Profile. Radeon Monster Profile (RMP) is ...
'Radeon Monster Profile' tool for RDNA 2: RX 6800 XT beats RTX 3090 Ti
GameSpot may get a commission from retail offers. Currently scheduled for release on November 2, Godzilla: Save the Earth will allow you to pit numerous incarnations of the titular giant monster and ...
Yahoo: ‘Monster studies' is a real thing - and it could help you through holiday anxiety
Add Yahoo as a preferred source to see more of our stories on Google. Professors Michael Chemers, left, and Renee Fox, co-directors of the Center For Monsters Studies at the University of California, ...
‘Monster studies' is a real thing - and it could help you through holiday anxiety